Accrual and retention of diverse patients in psychosocial cancer clinical trials

被引:5
|
作者
Hanvey, Grace Ann [1 ]
Padron, Adaixa [1 ]
Kacel, Elizabeth L. [1 ]
Cartagena, Gabriel [1 ]
Bacharz, Kelsey C. [1 ]
McCrae, Christina S. [1 ]
Robinson, Michael E. [1 ]
Waxenberg, Lori B. [1 ]
Antoni, Michael H. [2 ]
Berry, Richard B. [3 ]
Schultz, Gregory S. [4 ]
Castagno, Jacqueline [4 ]
Pereira, Deidre B. [1 ]
机构
[1] Univ Florida, Dept Clin & Hlth Psychol, Gainesville, FL 32611 USA
[2] Univ Miami, Dept Psychol, POB 248185, Coral Gables, FL 33124 USA
[3] Univ Florida, Div Pulm Crit Care & Sleep Med, Gainesville, FL USA
[4] Univ Florida, Dept Obstet & Gynecol, Gainesville, FL 32611 USA
基金
美国国家卫生研究院;
关键词
Cancer; clinical trials; recruitment; retention; health disparities; SLEEP QUALITY INDEX; PSYCHOMETRIC PROPERTIES; PARTICIPATION; POPULATIONS; MINORITIES; INVENTORY; BARRIERS; HEALTH; PAIN;
D O I
10.1017/cts.2022.380
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: Minority and older adult patients remain underrepresented in cancer clinical trials (CCTs). The current study sought to examine sociodemographic inequities in CCT interest, eligibility, enrollment, decline motivation, and attrition across two psychosocial CCTs for gynecologic, gastrointestinal, and thoracic cancers. Methods: Patients were approached for recruitment to one of two interventions: (1) a randomized control trial (RCT) examining effects of a cognitive-behavioral intervention targeting sleep, pain, mood, cytokines, and cortisol following surgery, or (2) a yoga intervention to determine its feasibility, acceptability, and effects on mitigating distress. Prospective RCT participants were queried about interest and screened for eligibility. All eligible patients across trials were offered enrollment. Patients who declined yoga intervention enrollment provided reasons for decline. Sociodemographic predictors of enrollment decisions and attrition were explored. Results: No sociodemographic differences in RCT interest were observed, and older patients were more likely to be ineligible. Eligible Hispanic patients across trials were significantly more likely to enroll than non-Hispanic patients. Sociodemographic factors predicted differences in decline motivation. In one trial, individuals originating from more urban areas were more likely to prematurely discontinue participation. Discussion: These results corroborate evidence of no significant differences in CCT interest across minority groups, with older adults less likely to fulfill eligibility criteria. While absolute Hispanic enrollment was modest, Hispanic patients were more likely to enroll relative to non-Hispanic patients. Additional sociodemographic trends were noted in decline motivation and geographical prediction of attrition. Further investigation is necessary to better understand inequities, barriers, and best recruitment practices for representative CCTs.
引用
收藏
页数:13
相关论文
共 50 条
  • [31] Multidisciplinary molecular tumour board: a tool to improve clinical practice and selection accrual for clinical trials in patients with cancer
    Rolfo, Christian
    Manca, Paolo
    Salgado, Roberto
    Van Dam, Peter
    Dendooven, Amelie
    Coelho, Andreia Machado
    Gandia, Jose Ferri
    Rutten, Annemie
    Lybaert, Willem
    Vermeij, Joanna
    Gevaert, Thomas
    Weyn, Christine
    Lefebure, Anneke
    Metsu, Sofie
    Van Laere, Steven
    Peeters, Marc
    Pauwels, Patrick
    ESMO OPEN, 2018, 3 (05)
  • [32] Multidisciplinary molecular tumour board: a tool to improve clinical practice and selection accrual for clinical trials in cancer patients
    Rolfo, C. D.
    Coelho, A. Machado
    Van Dam, P.
    Dendooven, A.
    Weyn, C.
    Rasschaert, M.
    Van Houten, L.
    Trinh, B. X.
    Van Meerbeeck, J.
    Pauwels, P.
    Peeters, M.
    ANNALS OF ONCOLOGY, 2016, 27
  • [33] Does empowering patients improve accrual to breast cancer trials?
    Arnaout, A.
    Kuchuk, I.
    Bouganim, N.
    Verma, S.
    Clemons, M.
    CANCER RESEARCH, 2012, 72
  • [34] Impact of pandemic on accrual of minority participants to interventional cancer clinical trials
    Wingard, Jaia
    Sallee, Vicki
    Gabriel, Peter Edward
    Doucette, Abigail
    Wormley, Wallace P.
    Grosso, Colleen M.
    Schnoll, Robert A.
    Washington, Armenta L.
    Pryma, Daniel A.
    Nathanson, Katherine
    Guerra, Carmen
    Vonderheide, Robert H.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [35] ACCRUAL TO CANCER CLINICAL-TRIALS - DIRECTIONS FROM THE RESEARCH LITERATURE
    GOTAY, CC
    SOCIAL SCIENCE & MEDICINE, 1991, 33 (05) : 569 - 577
  • [36] Accrual of adolescents and young adults (AYA) into cancer clinical trials in Canada
    Jafri, Mariam
    Willman, Corey
    Urton, Alison May
    Henning, Jan-Willem
    Abbott, Lesleigh S.
    Davison, Kelly
    Akra, Mohamed A.
    Seymour, Lesley
    Dancey, Janet Ellen
    Hay, Annette E.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [37] Report on a Delphi process and workshop to improve accrual to cancer clinical trials
    Bell, J. A. H.
    Balneaves, L. G.
    Kelly, M. T.
    Richardson, H.
    CURRENT ONCOLOGY, 2016, 23 (02) : 125 - 130
  • [38] Strategies to improve minority patient accrual to cancer clinical trials.
    Wujcik, DM
    Ikpeazu, C
    Chinratanalab, W
    Wolff, SN
    Kinnard, C
    McCullough, N
    Mason, HRC
    Stain, S
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 523S - 523S
  • [39] Addressing disparities in cancer clinical trials: a roadmap to more equitable accrual
    Hoin, Jon A.
    Carthon, Bradley C.
    Brown, Shantoria J.
    Durham, Lynn M.
    Garrot, L. Crain
    Ghamande, Sharad A.
    Pippas, Andrew W.
    Rivers, Brian M.
    Snyder, Cindy T.
    Gabram-Mendola, Sheryl Gordon Ann
    FRONTIERS IN HEALTH SERVICES, 2024, 4
  • [40] MONITORING ACCRUAL TO CLINICAL-TRIALS
    FRANKLIN, H
    WENT, G
    CONTROLLED CLINICAL TRIALS, 1988, 9 (03): : 260 - 261